Effect of cyclosporin A on the expression of inducible nitric oxide synthase in the gingiva of rats

Journal of Periodontology

Volumn 76, Issue 12, 2005, Pages 2260-2266

  Gau, Ching Hwa ^a,b   Chou, Tz Chong ^c   Chiu, Hsien Chung ^b   Shen, E Chin ^d   Nieh, Shin ^b   Chiang, Cheng Yang ^b   Fu, Earl ^b  

^a Kang Ning Junior College of Medical Care and Management   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

Cyclosporin; Gingiva; Nitric oxide synthase

Indexed keywords

CYCLOSPORIN A; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LOCALIZATION; GINGIVA OVERGROWTH; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RANDOMIZATION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CYCLOSPORINE; ENZYME INHIBITORS; GINGIVA; GINGIVAL OVERGROWTH; IMMUNOHISTOCHEMISTRY; LUNG; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 30944446459     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.12.2260     Document Type: Article

References (64)

1. Culotta E, Koshland DE Jr. NO news is good news. Science 1992;258:1862-1865.
2. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
3. Forstermann U, Schmidt HHW, Pollock JS, et al. Isoforms of nitric oxide synthase: Characterization and purification from different cell types. Biochem Pharmacol 1991;42:1849-1857.
4. Beasley D, Schwartz JH, Brenner BM. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87:602-608.
5. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
6. Wong JM, Billiar TR. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 1995;34:155-170.
7. Southan GJ, Szabo C. Commentary: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996;51:383-394.
8. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
9. Szabo C. The role of peroxynitrite in the patholphysiology of shock, inflammation and ischemia-reperfusion injury. Shock 1996;6:79-88.
10. Calne RY, Rolles K, Thiru S, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet 1979;2:1033-1036.
11. Caspers-Velu LE, Decaux G, Libert J. Cyclosporine in Behcet's disease resistant to conventional therapy. Ann Ophthalmol 1989;21:111-116, 118.
12. Starzl TE, Weil R 3rd, Iwatsuki S, et al. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980;151:17-26.
13. Fu E, Chou TC, Liu D, Chiu SC. Ameliorated effect of L-arginine supplementation on gingival morphology in cyclosporin-treated rats. J Periodontol 2000;71: 1737-1742.
14. Assis SM, Monteiro JL, Seguro AC. L-arginine and allopurinol protect against cyclosporine nephrotoxicity. Transplantation 1997;63:1070-1073.
15. Andoh TF, Gardner MP, Bennett WM. Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 1997;64: 1236-1240.
16. Gardner MP, Houghton DC, Andoh TF, Lindsley J, Bennett WM. Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation 1996;61:1506-1512.
17. Shimizu Y, Sakai M, Umemura Y, Ueda H. Immunohistochemical localization of nitric oxide synthase in normal human skin: Expression of endothelial-type and inducible-type nitric oxide synthase in keratinocytes. J Dermatol 1997;24:80-87.
18. Wang R, Ghahary A, Shen YJ, Scott PG, Tredget EE. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 1996;106: 419-427.
19. Chen S, Wu J, Wang S. An investigation of immunoreactive substances in normal gingival tissue and periodontitis tissue. Zhonghua Bing Li Xue Za Zhi 1996;25:340-342.
20. Lohinai XZ, Szekely AD, Benedek P, Csillag A. Nitric oxide synthase containing nerves in the cat and dog dental pulp and gingiva. Neurosci Lett 1997;227: 91-94.
21. Blix IJ, Helgeland K. LPS form Actinobacillus actinomycemcomitans and production of nitric oxide in murine macrophages J774. Eur J Oral Sci 1998;106: 576-581.
22. Szabo C, Mitchell JA, Gross SS, Thiemermann C, Vane JR. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J Pharmacol Exp Ther 1993;265:674-680.
23. Hattori Y, Kasai K, So S, Hattori S, Banba N, Shimoda S. Effects of calcium channel antagonists on the induction of nitric oxide synthase in cultured cells by immunostimulants. Life Sci 1995;57:1833-1840.
24. Ramon Y, Behar S, Kishon Y, Engelberg IS. Gingival hyperplasia caused by nifedipine - A preliminary report. Int J Cardiol 1984;5:195-206.
25. Lederman D, Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Oral Surg Oral Med Oral Pathol 1984;57:620-622.
26. Fu E, Nieh S, Hsiao CT, Hsieh YD, Wikesjö UM, Shen EC. Nifedipine-induced gingival overgrowth in rats: Brief review and experimental study. J Periodontol 1998;69:765-771.
27. Pell MA, Rosano TG, Brayman KL, Freed BM, Shaw LM, Lempert N. Predominance of native cyclosporine over metabolites in rat blood and tissue. Transplant Proc 1988;20(Suppl. 2):674-679.
28. Fu E, Nieh S, Wikesjö UM, Lin FG, Shen EC. Gingival overgrowth and dental alveolar alterations: Possible mechanisms of cyclosporin-induced tooth migration. J Periodontol 1997;68:1231-1236.
29. Lohinai Z, Benedek P, Feher E, et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123: 353-360.
30. Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 1998;31:643-648.
31. Wu CC, Hong HJ, Chou TC, Ding YA, Yen MH. Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats. Biochem Biophys Res Commun 1996;228:459-466.
32. Rao MR, Hutcheson AE, Markov A. Changes in the cardiovascular nitric oxide pathway in cyclosporin-A treated rats. Drug Chem Toxicol 1998;21:27-34.
33. Gaston RS, Schlessinger SD, Sanders PW, Barker CV, Curtis JJ, Warnock DG. Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients. J Am Soc Nephrol 1995;5:1426-1433.
34. Schaffer MR, Tantry U, Gross SS, Wasserburg HL, Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996;63:237-240.
35. Schaffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997; 158:2375-2381.
36. Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995; 76:305-309.
37. Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 1995;207:120-125.
38. Wang R, Ghahary A, Shen YJ, Scott PG, Tredget EE. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts. J Invest Dermatol 1997;108:438-444.
39. Benrath J, Zimmermann M, Gillardon F. Substance P and nitric oxide mediate would healing of ultraviolet photodamaged rat skin: Evidence for an effect of nitric oxide on keratinocyte proliferation. Neurosci Lett 1995; 200:17-20.
40. Heck DE, Laskin DL, Gardner CR, Laskin JD. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 1992;267:21277-21280.
41. Krischel V, Bruch-Gerharz D, Suschek C, Kroncke KD, Ruzicka T, Kolb-Bachofen V. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J Invest Dermatol 1998;111:286-291.
42. Khoori AH, Einollahi B, Ansari G, Moozeh MB. The effect of cyclosporine with and without nifedipine on gingival overgrowth in renal transplant patients. J Can Dent Assoc 2003;69:236-241.
43. Spolidorio LC, Spolidorio DM, Neves KA, Gonzaga HF, Almeida OP. Morphological evaluation of combined effects of cyclosporin and nifedipine on gingival overgrowth in rats. J Periodontal Res 2002;37:192-195.
44. Bokenkamp A, Bohnhorst B, Beier C, Albers N, Offner G, Brodehl J. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994; 8:181-185.
45. Margiotta V, Pizzo I, Pizzo G, Barbaro A. Cyclosporin-and nifedipine-induced gingival overgrowth in renal transplant patients: Correlations with periodontal and pharmacological parameters, and HLA-antigens. J Oral Pathol Med 1996;25:128-134.
46. O'Valle F, Mesa F, Aneiros J, et al. Gingival overgrowth induced by nifedipine and cyclosporin A. Clinical and morphometric study with image analysis. J Clin Periodontol 1995;22:591-597.
47. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
48. Chiu HC, Fu E, Chiang CY. Does nifedipine aggravate the cyclosporin-induced gingival overgrowth? An experiment in rats. J Periodontol 2001;72:532-537.
49. Kosaka H, Yoneyama H, Zhang L, Fujii S, Yamamoto A, Igarashi J. Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine. FASEB J 2003;17:636-643.
50. Noris M, Todeschini M, Cassis P, et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004;43:614-622.
51. Schincaglia GP, Forniti F, Cavallini R, Piva R, Calura G, del Senno L. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992;21: 181-185.
52. Zebrowski EJ, Pylypas SP, Odlum O, Johnson RB. Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine. J Periodontol 1994;65:565-567.
53. Yamada H, Nishimura F, Naruishi K, et al. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol 2000;71: 955-960.
54. Tipton DA, Stricklin GP, Dabbous MK. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991;46:152-165.
55. Tipton D, Dabbous M. Binding and subcellular distribution of cyclosporine in human fibroblasts. J Cell Biochem 1993;51:345-352.
56. Iacopino AM, Doxey D, Cutler CW, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
57. Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM. Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996;67:271-278.
58. Plemons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, Iacopino AM. PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth. J Periodontol 1996; 67:264-270.
59. Williamson MS, Miller EK, Plemons J, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: Possible mechanism for gingival overgrowth. J Periodontol 1994;65:895-904.
60. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1 beta and interleukin-6 expression in gingiva: Implications for gingival overgrowth. J Periodontol 1999;70:294-300.
61. Matsuki Y, Yamamoto T, Hara K. Detection of inflammatory cytokine messenger RNA (m RNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry. Immunology 1992;76:42-47.
62. Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells: Macrophage-dependent synthesis of BSF-2/IL-6 by T-cells. J Immunol 1988;141:1529-1535.
63. Turner K, Pflugfelder SC, Ji Z, Feuer WJ, Stern M, Reis BL. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea 2000;19:492-496.
64. Garcia JE, Lopez AM, de Cabo MR, et al. Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level. Mediators Inflamm 1999;8:253-259.